- Launched two major new products: the Thermogard XP (TM) Temperature
Management system, which is designed to provide an enhanced level of
therapeutic cooling power; and the Quattro (TM) catheter, a
four-balloon heat exchange catheter that provides increased surface
area and power with triple lumen central venous access.
-- Clinical Validation
- Alsius' products were featured in over 85 articles, abstracts and
presentations in peer-reviewed journals or medical meetings around
the world, including the Congress of Neurological Surgeons, the
American College of Surgeons, European Burns Association, the
International Hypothermia Symposium, and the Neurocritical Care
- The peer-reviewed journal, Critical Care, published a study in
August comparing different cooling methods and concluded that Alsius
intravascular cooling demonstrated the fastest cooling rates and was
the most reliable for maintaining stable body temperature. The study
evaluated Alsius intravascular temperature management, conventional
(cold intravenous fluids and/or cold packs), water and air
circulating blankets and water circulating gel-coated pads.
Conference Call Details
Alsius will host a conference call and webcast on March 13, 2008 at 4:30 p.m. Eastern Time. To participate in the teleconference, participants in the U.S. and Canada may call 877-440-5791 while international callers should dial 719-325-4879. No password is required for the live teleconference. To access the webcast, please go to the Investor Relations page on our website http://www.alsius.com.
A telephone replay of the conference call will be available 90 minutes
after the call concludes on March 13 through March 31, 2008.
|SOURCE Alsius Corporation|
Copyright©2008 PR Newswire.
All rights reserved